laryngeal transplantation
TRANSCRIPT
![Page 1: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/1.jpg)
LARYNGEAL TRANSPLANTATION
Department of Otorhinolaryngologyand Head & Neck SurgerySestre milosrdnice hospitalZagreb
mr.sc. Dražen Shejbalmr.sc. Mirko Ivkić
![Page 2: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/2.jpg)
LIVER, LUNG, HEART….
![Page 3: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/3.jpg)
LARYNX: QUALITY OF LIFE
![Page 4: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/4.jpg)
POTENTIAL IMPACT
- 2,000 total laryngectomies (majority of these patients probably not candidates for laryngeal transplantation)
- Benign laryngeal neoplasms are uncommon
- Laryngeal trauma resulting in laryngectomy or incompetent larynx even less common
![Page 5: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/5.jpg)
Boles- 1960 applied objective criteria for laryngeal transplantation
1. phonation dependent on pulmonary airflow and vocal fold motion,
2. degluttion without aspiration 3. functional oral and nasal passages enabling
olfactory and gustatory sensation
• Late 1960’s- Ogura, Takenouchi, and Silver- Vary vascular reanastomosis, reimplantation, and orthotopic canine transplants
![Page 6: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/6.jpg)
PIONEERS
• February 11, 1969- Klyuskens and Ringoir attempted human laryngeal transplant in Belgium-
![Page 7: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/7.jpg)
Tehnical limitations, non selective immunosuppresion, ethical concerns
![Page 8: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/8.jpg)
1987; Marshall Strome and coll.
• Revascularisation
• Reinnervation
• Rejection
• Preservation
• Ethic consideration ( 100.000$)
![Page 9: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/9.jpg)
REVASCULARISATION
• 45 min
• superior thyroid a. provides > 80% of blood supply
• Larynx with thyroid gland
• 3 phase study of revascularisation
![Page 10: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/10.jpg)
![Page 11: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/11.jpg)
![Page 12: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/12.jpg)
SEPSIS-CANCERRECCURENCE
REJECTION
IMMUNOSUPPRESSION
![Page 13: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/13.jpg)
IMMUNOSUPPRESSION
• Larynx and trachea- susceptible to rejection much like other tissues
• Mucosa is the major antigenic structure
• Cartilage is only midly immunogenic
![Page 14: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/14.jpg)
REJECTION
• MUROMONAB CD 3
• CYCLOSPORINE
• METHYLPREDNISOLONE
• MYCOPHELONATE MOFETIL
![Page 15: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/15.jpg)
Malignant disease in patients with long-term renal transplants.
Gaya SB, Rees AJ, Lechler RI, Williams G, Mason PD.
Transplantation. 1995 Department of Medicine, Royal Postgraduate Medical School,
Hammersmith Hospital, London, United Kingdom.• 274• cumulative risks of tumor development were
18% 10 years 50% 20 years.
• Skin tumors were the most common• lymphoma, renal, bladder, and bronchial
carcinoma.
![Page 16: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/16.jpg)
Malignant neoplasms following cardiac transplantation.
Curtil A, Robin J, Tronc F, Ninet J, Boissonnat P, Champsaur G.
Eur J Cardiothorac Surg. 1997 Service de Chirurgie Thoracique et Cardiovasculaire C, Louis Pradel
Cardiovascular Hospital, Lyon, France • 6.7% neoplasms developed in 18 of the 267 patients
at risk• 4.1% lung neoplasms (especially adenocarcinoma)
11 of 268 patients,
• 78% significant smoking history (14)
• high incidence of lung neoplasms (especially adenocarcinoma) which can be correlated with a heavy cigarette use in the study population.
![Page 17: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/17.jpg)
Head and neck cancer in cardiothoracic transplant recipients.
Pollard JD, Hanasono MM, Mikulec AA, Le QT, Terris DJLaryngoscope. 2000
Division of Otolaryngology--Head and Neck Surgery, Stanford University Medical Center, California
• 1069 heart (n = 855), heart/lung (n = 111), and lung (n = 103) transplants were performed
• 11% non-lymphomatous malignancies
• 51% head and neck• 96% cutaneous in origin
80% squamous cell carcinoma
16% were basal cell carcinoma
• 68% of cancer patients were smokers and
24% had significant alcohol use
• 55% of cancer patients died as a direct result of cancer
![Page 18: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/18.jpg)
Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on
outcome.Klintmalm GB. Ann Surg. 1998
Department of Surgery, Baylor University Medical Center, Dallas, Texas
• 422 patients • 190 (46%) have died, 99 free of tumor and 91 with
tumor. • overall patient survival was 44% at 5 years. • 42% - recurrence in liver 28% lungs • 26% hepatitis B 33% hepatitis C.• Current policy in US: + HIV test does not exclude
transplantation
![Page 19: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/19.jpg)
IMMUNOSUPPRESSION DISCUSSION
• Immunosuppression increased cancer risk
• “homming”
• Larynx transplantation: time is on our side
• Modern immunosuppression
![Page 20: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/20.jpg)
REINNERVATION
• Laryngeal synkinesis- generalized axon regrowth: non-specific reinnervation of both adductor and abductor intrinsic musculature
• Sensory reinnervation for swallowing and airway protection
![Page 21: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/21.jpg)
Risk of synkinesis is eliminated by reinnervating the abductor and adductor individually
![Page 22: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/22.jpg)
![Page 23: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/23.jpg)
•Average lenghts of the abductor and adductor 5,4 – 5,6, min. diameter 0,5 mm
POST. CRICOARYTENOID M. AND ARYTENOID CARTILAGE
BRANC. TO INTERARYTENOID M.
INFERIOR CRICOTHYROID LIG.
BRAN. TO POSTERIOR CRICOARITENOID M.
RIGHT RECCURENS N.
SCALE 1 MM
![Page 24: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/24.jpg)
REINNERVATION BANKING
![Page 25: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/25.jpg)
![Page 26: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/26.jpg)
Tucker, H.M. and Rusnov, M. Laryngeal reinnervation for unilateral vocal cord paralysis:Long term results. Ann Otolaryngol. 1981
![Page 27: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/27.jpg)
PRESERVATION
• 45 minutes
• Heparinized saline with cold: 3 – 6 hours
• Hypothermic perfusion techinques: 48 hours – infinitely more complex, introducing the potential for mechanical failure, incrased incidence of infection
![Page 28: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/28.jpg)
PRESERVATION
• D uration
• U seful
• R educes swelling
• E lectrolyte balance
• X factor
![Page 29: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/29.jpg)
![Page 30: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/30.jpg)
ETHICAL CONSIDERATION
• A question of acceptable risk versus potential benefit
• Transplanting a ‘non-vital’ organ
• Who is financially responsible- can the government or private insurers regualte?
![Page 31: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/31.jpg)
100.000 $
• If rejection occurred, transplant could be removed without great risk of death
• Safety more attainable:
1. microvascular technics
2. fiberoptic endoscopy
3. follow for early rejection
![Page 32: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/32.jpg)
Potter, et al., UK survey of 372 patients after total laryngectomy:
1. 75% would like an laryngeal transplantation if it were safe
2. Figure remained at 50% even if there was little chance for normal speech
3. Only 20% would accept a graft if long term immunosuppression were required
![Page 33: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/33.jpg)
LARYNGEAL TRANSPLANTATION
all expected complications were successfully overcome and the expected failures did not occur.
![Page 34: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/34.jpg)
![Page 35: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/35.jpg)
LARYNX IS A MISTERY
• Third postoperative day: “ HELLO”
• At one month both vocal fold was lateral, a voice was breathy , generatered by the aryepiglottic folds
• 6 MONTHS A BOTH FOLDS WAS IN THE MIDLINE
![Page 36: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/36.jpg)
“ HELLO !?”
• “LEFT RECCURENT NERVE OF THE TRANSPLANT WAS REINNERVATED BY THE PATIENT’S SMALL REGIONAL MOTOR NERVES”
• NORMAL RANGE- 36 MONTHS
![Page 37: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/37.jpg)
RESPIRATION AND SWALLOWING
• Initial plane: close tracheal stoma year after laser chordotomy of the left vocal fold
• Attempts to provide self closing valve were not succesful
• Right side trachea- touch but not cugh• Left no response• 3 months glottis and supraglotis were sensitive to
touch, initiated a severe cugh• Purposeful swallowing and full oral alimentation
returned soon thereafter• Taste and smell returned
![Page 38: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/38.jpg)
THYROID EFFECTS
• 83 % was in the donor’s thyroid lobes
• 17 % in the patient’s
• Donor’s parathyroid glands were functional after a 10 hour period of ischemia
• Patient’s parathyroid functioning normally
![Page 39: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/39.jpg)
COMPLICATION
-One episode of REJECTION after 15 months ( declined quality of voice, larynx edema)
- returned to normal within three days
- INFECTION: three episodes of tracheobronchitis ( amoxicillin clavulonate)
- pneumocistis carinii pneumonia
![Page 40: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/40.jpg)
ETHIC´S CANCEROPHOBIA
• Vital and non vital
• ESSENTIAL AND NOT ESSENTIAL
• SPEAK = HUMAN
![Page 41: Laryngeal transplantation](https://reader034.vdocument.in/reader034/viewer/2022052304/55a09d101a28ab6b6a8b47c7/html5/thumbnails/41.jpg)